Efficacy, toxicity, and costs are all important components of formulating an appropriate care pathway for unresectable locoregionally advanced and metastatic NSCLC.
Kimberly A. Bergstrom, PharmD
Advertisement
Articles by Kimberly A. Bergstrom, PharmD
Advertisement
Latest Updated Articles
- Management of Unresectable Locoregionally Advanced and Metastatic Nonsquamous NSCLC
Published: April 5th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Regular Melatonin Supplementation May Hide Hidden Heart Complications
2
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
3
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
4
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
5
